Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H24N2O2 |
Molecular Weight | 324.4168 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3
InChI
InChIKey=LOUPRKONTZGTKE-LHHVKLHASA-N
InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19+,20-/m0/s1
Molecular Formula | C20H24N2O2 |
Molecular Weight | 324.4168 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:15:55 UTC 2023
by
admin
on
Fri Dec 15 15:15:55 UTC 2023
|
Record UNII |
ITX08688JL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC01BA01
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
WHO-ATC |
C01BA01
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
WHO-ATC |
C01BA71
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
NDF-RT |
N0000175426
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
WHO-VATC |
QC01BA51
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
NDF-RT |
N0000182135
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
LIVERTOX |
NBK548869
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
WHO-VATC |
QC01BA71
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
||
|
WHO-ATC |
C01BA51
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB00908
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
9068
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | RxNorm | ||
|
Quinidine
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
N0000182137
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | Cytochrome P450 2D6 Inhibitors [MoA] | ||
|
SUB04166MIG
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
D011802
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
2342
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
441074
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
ITX08688JL
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
QUINIDINE
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
m9446
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | Merck Index | ||
|
225
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
DTXSID4023549
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
CHEMBL1294
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
200-279-0
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
28593
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
2346
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
C793
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
100000092616
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
56-54-2
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY | |||
|
ITX08688JL
Created by
admin on Fri Dec 15 15:15:55 UTC 2023 , Edited by admin on Fri Dec 15 15:15:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE |
in vitro ER in the MDCK-MDR1 cell line from National Institutes of Health
EFFLUX RATIO
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INHIBITOR |
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SOLVATE->ANHYDROUS |
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
Metabolite to parent drug ratio in non-uraemic human plasma.
METABOLITE TO PARENT DRUG RATIO
PLASMA; URINE
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
quinidine is metabolized by CYP3A4 (In vitro)
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
MAJOR
FECAL; PLASMA; URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
INTERNATIONAL PHARMACOPEIA
|
||
|
PARENT -> IMPURITY |
Not Specified
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
Not Specified
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
INTERNATIONAL PHARMACOPEIA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
Heart Failure PHARMACOKINETIC |
|
||
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC |
|
||